Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack.

Thaler D.

Lancet Neurol. 2018 Jul;17(7):573-574. doi: 10.1016/S1474-4422(18)30198-4. Epub 2018 Jun 7. No abstract available.

2.

A priori, a posteriori, and back again: A priori posteriori?

Thaler DE, Lioutas VA.

Neurology. 2018 Jun 6. pii: 10.1212/WNL.0000000000005737. doi: 10.1212/WNL.0000000000005737. [Epub ahead of print] No abstract available.

PMID:
29875220
3.

Correction: Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.

Leung LY, Han PKJ, Lundquist C, Weinstein G, Thaler DE, Kent DM.

PLoS One. 2018 May 16;13(5):e0197706. doi: 10.1371/journal.pone.0197706. eCollection 2018.

4.

Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.

Saver JL, Mattle HP, Thaler D.

Stroke. 2018 Jun;49(6):1541-1548. doi: 10.1161/STROKEAHA.117.018153. Epub 2018 May 14. Review. No abstract available.

PMID:
29760277
5.

Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD.

Stroke. 2018 Jun;49(6):1443-1450. doi: 10.1161/STROKEAHA.117.020322. Epub 2018 May 2.

PMID:
29720435
6.

Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.

Leung LY, Han PKJ, Lundquist C, Weinstein G, Thaler DE, Kent D.

PLoS One. 2018 Mar 29;13(3):e0194971. doi: 10.1371/journal.pone.0194971. eCollection 2018. Erratum in: PLoS One. 2018 May 16;13(5):e0197706.

7.

Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention.

Tirschwell DL, Turner M, Thaler D, Choulerton J, Marks D, Carroll J, MacDonald L, Smalling RW, Koullick M, Gu NY, Saver JL.

J Med Econ. 2018 Apr 13:1-10. doi: 10.1080/13696998.2018.1456445. [Epub ahead of print]

PMID:
29564942
8.

Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.

Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, Ganesh SK, Gulati R, Lindsay ME, Mieres JH, Naderi S, Shah S, Thaler DE, Tweet MS, Wood MJ; American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council.

Circulation. 2018 May 8;137(19):e523-e557. doi: 10.1161/CIR.0000000000000564. Epub 2018 Feb 22. Review.

9.

Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicates increased risk for intracranial hemorrhage.

Kneihsl M, Niederkorn K, Deutschmann H, Enzinger C, Poltrum B, Fischer R, Thaler D, Hermetter C, Wünsch G, Fazekas F, Gattringer T.

J Neurointerv Surg. 2017 Dec 28. pii: neurintsurg-2017-013617. doi: 10.1136/neurintsurg-2017-013617. [Epub ahead of print]

PMID:
29288194
10.

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.

11.

Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.

Melkumova E, Thaler DE.

Interv Cardiol Clin. 2017 Oct;6(4):487-493. doi: 10.1016/j.iccl.2017.05.005. Epub 2017 Jun 29. Review.

PMID:
28886840
12.

Longitudinal Care for Young Adults With Stroke.

Leung LY, Melkumova E, Thaler DE.

JAMA Neurol. 2017 Oct 1;74(10):1163-1164. doi: 10.1001/jamaneurol.2017.1874. No abstract available.

PMID:
28828467
13.
14.

More to Atherosclerosis Than Stenosis: Symptomatic Carotid Artery With Intraplaque Hemorrhage.

Rai S, Thaler DE, Salehi P, Madan N, Leung LY.

Stroke. 2017 Apr;48(4):e104-e107. doi: 10.1161/STROKEAHA.117.016923. Epub 2017 Mar 14. Review. No abstract available.

16.

Fatal subarachnoid hemorrhage following ischemia in vertebrobasilar dolichoectasia.

Sokolov AA, Husain S, Sztajzel R, Croquelois A, Lobrinus JA, Thaler D, Städler C, Hungerbühler H, Caso V, Rinkel GJ, Michel P.

Medicine (Baltimore). 2016 Jul;95(27):e4020. doi: 10.1097/MD.0000000000004020.

17.

Toward a microbial Neolithic revolution in buildings.

Thaler DS.

Microbiome. 2016 Mar 29;4:14. doi: 10.1186/s40168-016-0157-2. Review.

18.

Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.

Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE.

J Am Coll Cardiol. 2016 Mar 1;67(8):907-17. doi: 10.1016/j.jacc.2015.12.023. Review.

19.

The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.

Wessler BS, Kent DM, Thaler DE, Ruthazer R, Lutz JS, Serena J.

Cerebrovasc Dis. 2015;40(1-2):52-8. doi: 10.1159/000430998. Epub 2015 Jul 11.

20.

Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.

Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Weimar C, Serena J, Meier B, Mattle HP, Di Angelantonio E, Paciaroni M, Schuchlenz H, Homma S, Lutz JS, Thaler DE.

Eur Heart J. 2015 Sep 14;36(35):2381-9. doi: 10.1093/eurheartj/ehv252. Epub 2015 Jul 3. Review.

21.

Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA.

Jassam YN, Thaler DE.

Oxf Med Case Reports. 2014 Dec 27;2014(9):162-3. doi: 10.1093/omcr/omu061. eCollection 2014 Dec.

22.
23.

Response to Cassidy and Cote.

Thaler DE.

J Stroke Cerebrovasc Dis. 2015 Apr;24(4):902-3. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.015. Epub 2015 Feb 25. No abstract available.

PMID:
25724244
24.

Exercises in clinical reasoning: a confusing interaction.

Shah UA, Henderson MC, Abourjaily P, Thaler D, Rencic J.

J Gen Intern Med. 2015 Jun;30(6):860-3. doi: 10.1007/s11606-014-3173-6. Epub 2015 Jan 27. No abstract available.

25.

Challenges in representation learning: a report on three machine learning contests.

Goodfellow IJ, Erhan D, Luc Carrier P, Courville A, Mirza M, Hamner B, Cukierski W, Tang Y, Thaler D, Lee DH, Zhou Y, Ramaiah C, Feng F, Li R, Wang X, Athanasakis D, Shawe-Taylor J, Milakov M, Park J, Ionescu R, Popescu M, Grozea C, Bergstra J, Xie J, Romaszko L, Xu B, Chuang Z, Bengio Y.

Neural Netw. 2015 Apr;64:59-63. doi: 10.1016/j.neunet.2014.09.005. Epub 2014 Dec 29.

PMID:
25613956
26.

Management of Asymptomatic Carotid Stenosis [Internet].

Raman G, Kitsios GD, Moorthy D, Hadar N, Dahabreh IJ, O'Donnell TF, Thaler DE, Feldmann E, Lau J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Aug 27.

27.

Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.

Thaler DE, Ruthazer R, Weimar C, Serena J, Mattle HP, Nedeltchev K, Mono ML, Di Angelantonio E, Elkind MS, Di Tullio MR, Homma S, Michel P, Meier B, Furlan AJ, Lutz JS, Kent DM.

Neurology. 2014 Nov 18;83(21):1954-7. doi: 10.1212/WNL.0000000000001007. Epub 2014 Oct 22.

28.

Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies.

Hadar N, Raman G, Moorthy D, O'Donnell TF, Thaler DE, Feldmann E, Lau J, Kitsios GD, Dahabreh IJ.

Cerebrovasc Dis. 2014;38(3):163-73. doi: 10.1159/000365206. Epub 2014 Oct 9. Review.

29.

Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the american heart association/american stroke association.

Biller J, Sacco RL, Albuquerque FC, Demaerschalk BM, Fayad P, Long PH, Noorollah LD, Panagos PD, Schievink WI, Schwartz NE, Shuaib A, Thaler DE, Tirschwell DL; American Heart Association Stroke Council.

Stroke. 2014 Oct;45(10):3155-74. doi: 10.1161/STR.0000000000000016. Epub 2014 Aug 7. Review. Erratum in: Stroke. 2016 Nov;47(11):e261.

30.

Case misclassification in studies of spinal manipulation and arterial dissection.

Cai X, Razmara A, Paulus JK, Switkowski K, Fariborz PJ, Goryachev SD, D'Avolio L, Feldmann E, Thaler DE.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2031-2035. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.007. Epub 2014 Jul 30.

31.

DNA barcoding works in practice but not in (neutral) theory.

Stoeckle MY, Thaler DS.

PLoS One. 2014 Jul 2;9(7):e100755. doi: 10.1371/journal.pone.0100755. eCollection 2014.

32.

Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs.

Thaler DE, Ruthazer R, Weimar C, Mas JL, Serena J, Di Angelantonio E, Papetti F, Homma S, Mattle HP, Nedeltchev K, Mono ML, Jaigobin C, Michel P, Elkind MS, Di Tullio MR, Lutz JS, Griffith J, Kent DM.

Neurology. 2014 Jul 15;83(3):221-6. doi: 10.1212/WNL.0000000000000589. Epub 2014 Jun 13.

33.

Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis.

Jain P, Hsu T, Arai M, Biermann K, Thaler DS, Nguyen A, González PA, Tufariello JM, Kriakov J, Chen B, Larsen MH, Jacobs WR Jr.

MBio. 2014 Jun 3;5(3):e01245-14. doi: 10.1128/mBio.01245-14.

34.

Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database".

Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM.

Circ Cardiovasc Imaging. 2014 May;7(3):573. doi: 10.1161/CIRCIMAGING.114.001756. No abstract available.

35.

In memoriam: Theodore Leon Munsat, MD (1930-2013).

Adelman LS, Thaler DE.

JAMA Neurol. 2014 Apr;71(4):516. doi: 10.1001/jamaneurol.2013.6402. No abstract available.

PMID:
24733270
36.

Association of ischemic stroke, hormone therapy, and right to left shunt in postmenopausal women.

Greep NC, Liebeskind DS, Gevorgyan R, Truong T, Cua B, Tseng CH, Dodick DW, Demaerschalk BM, Thaler DE, Tobis JM.

Catheter Cardiovasc Interv. 2014 Sep 1;84(3):479-85. doi: 10.1002/ccd.25431. Epub 2014 Mar 11.

PMID:
24677643
37.

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.

Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM.

Circ Cardiovasc Imaging. 2014 Jan;7(1):125-31. doi: 10.1161/CIRCIMAGING.113.000807. Epub 2013 Nov 8.

38.

Response to letter regarding article, "Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials".

Kent DM, Kitsios GD, Thaler DE.

Stroke. 2013 Dec;44(12):e234. doi: 10.1161/STROKEAHA.113.003654. Epub 2013 Nov 5. No abstract available.

39.

Transient ischemic attack: omen and opportunity.

Sonni S, Thaler DE.

Cleve Clin J Med. 2013 Sep;80(9):566-76. doi: 10.3949/ccjm.80a.12141. Review.

PMID:
24001965
40.

Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials.

Kitsios GD, Thaler DE, Kent DM.

Stroke. 2013 Sep;44(9):2640-3. doi: 10.1161/STROKEAHA.113.001773. Epub 2013 Jul 18. No abstract available.

41.

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.

Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE.

Neurology. 2013 Aug 13;81(7):619-25. doi: 10.1212/WNL.0b013e3182a08d59. Epub 2013 Jul 17.

42.

Do we know, or do we believe?

Thaler DE, Kimmelstiel C.

Catheter Cardiovasc Interv. 2013 Jul 1;82(1):130-1. doi: 10.1002/ccd.25015. No abstract available.

PMID:
23788391
43.

Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis.

Raman G, Moorthy D, Hadar N, Dahabreh IJ, O'Donnell TF, Thaler DE, Feldmann E, Lau J, Kitsios GD.

Ann Intern Med. 2013 May 7;158(9):676-685. doi: 10.7326/0003-4819-158-9-201305070-00007. Review.

PMID:
23648949
44.

Patent foramen ovale science: keeping the horse in front of the cart.

Salem DN, Thaler DE.

J Am Coll Cardiol. 2013 Jul 2;62(1):42-3. doi: 10.1016/j.jacc.2013.04.016. Epub 2013 May 1. No abstract available.

45.

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.

47.

Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale.

Thaler DE, Ruthazer R, Di Angelantonio E, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Serena J, Weimar C, Kent DM.

Stroke. 2013 Mar;44(3):675-80. doi: 10.1161/STROKEAHA.112.677039. Epub 2013 Jan 22.

48.

Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth?

Thaler DE, Wahl A.

Stroke. 2012 Nov;43(11):3147-9. doi: 10.1161/STROKEAHA.112.659599. Epub 2012 Sep 18. No abstract available.

49.

Building Partner Health Capacity with U.S. Military Forces: Enhancing AFSOC Health Engagement Missions.

Thaler DE, Cecchine G, Wong A, Jackson T.

Rand Health Q. 2012 Sep 1;2(3):12. eCollection 2012 Fall.

50.

The risk of paradoxical embolism (RoPE) study: initial description of the completed database.

Thaler DE, Di Angelantonio E, Di Tullio MR, Donovan JS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Ruthazer R, Serena J, Weimar C, Elkind MS, Kent DM.

Int J Stroke. 2013 Dec;8(8):612-9. doi: 10.1111/j.1747-4949.2012.00843.x. Epub 2012 Aug 9.

Supplemental Content

Loading ...
Support Center